Liposome Drug Delivery Market, By Product, By Technology, By Indication, By End User, By Geography

Description

The liposome drug delivery market is estimated to be valued at USD 5,482.2 Mn in 2024 and is expected to reach USD 9,935.6 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.9% from 2024 to 2031.

Report Coverage		Report Details
Base Year:	2023	Market Size in 2024:	US$ 5,482.2 Mn
Historical Data for:	2019 To 2023	Forecast Period:	2024 To 2031
Forecast Period 2024 to 2031 CAGR:	8.90%	2031 Value Projection:	US$ 9,935.6 Mn

Figure. Liposome Drug Delivery Market Share (%), By Region 2024

Liposome drug delivery is a promising approach for targeted drug delivery and release. Liposomes are artificially prepared vesicles made up of lipid bilayers similar to cell membranes that can encapsulate both hydrophobic and hydrophilic drugs within their aqueous core and lipid membranes respectively. This enables liposomes to serve as nanocarriers for the delivery of various therapeutic agents to target sites, enhancing their efficacy and bioavailability while reducing toxicity to healthy tissues. Recent advancements in liposomal formulations have improved drug loading capacity, stability in blood circulation as well as active or passive targeting capabilities, making them potential candidates for delivery of anti-cancer drugs, vaccines, gene therapies, and others.

Market Dynamics:

The global liposome drug delivery market is driven by the rising prevalence of cancer and other chronic diseases, increasing demand for targeted drug delivery systems, and growing R&D investments from key players in the nanomedicine and biopharma sectors. However, high costs associated with drug development and regulatory approvals continue to restrain broader market adoption. Growing interest in personalized medicine and nanotechnology-based formulations present significant opportunities for liposome drugs manufacturers. Strategic collaborations between drug makers and liposome technology providers are helping expand therapeutic applications into areas such as infectious diseases, pain management, and autoimmune disorders.

Key Features of the Study:

This report provides an in-depth analysis of the global liposome drug delivery market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global liposome drug delivery market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Gilead Sciences, Inc., Luye Pharma Group, Ipsen Biopharmaceuticals, Inc., Pacira Pharmaceuticals, Inc., Acuitas Therapeutics, LIPOSOMA B.V., Takeda Pharmaceutical Company Limited, Taiwan Liposome Company, Ltd., Endo International, and Jazz Pharmaceuticals plc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global liposome drug delivery market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global liposome drug delivery market

Detailed Segmentation-

Product:
- Liposomal Paclitaxel
- Liposomal Doxorubicin
- Liposomal Amphotericin B
- Others
Technology:
- Stealth Liposome Technology
- Non-PEGylated Liposome Technology
- DepoFoam Liposome Technology
Indication:
- Fungal Diseases
- Pain Management
- Cancer Therapeutics
- Others
End User:
- Hospitals
- Clinics
- Research Laboratories
- Others
Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Company Profiles:
- Gilead Sciences, Inc.
- Luye Pharma Group
- Ipsen Biopharmaceuticals, Inc.
- Pacira Pharmaceuticals, Inc.
- Acuitas Therapeutics
- LIPOSOMA B.V.
- Takeda Pharmaceutical Company Limited
- Taiwan Liposome Company, Ltd.
- Endo International
- Jazz Pharmaceuticals plc

Product Code: CMI6883

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Product
- Market Snapshot, By Technology
- Market Snapshot, By Indication
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Market Trends
Recent Developments
Acquisitions and Partnerships Scenario
Regulatory Scenario
Product Launches/Approvals
Funding and Investments
PEST Analysis
Porter's Analysis

4. Global Liposome Drug Delivery Market - Impact of Coronavirus (COVID-19) Pandemic

Overall Impact
Government Initiatives
COVID-19 impact on the market

5. Global Liposome Drug Delivery Market, By Product, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Liposomal Paclitaxel
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Liposomal Doxorubicin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Liposomal Amphotericin B
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Nasal Endoscopes
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

6. Global Liposome Drug Delivery Market, By Technology, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Stealth Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Non-PEGylated Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
DepoFoam Liposome Technology
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

7. Global Liposome Drug Delivery Market, By Indication, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Fungal Diseases
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Pain Management
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Cancer Therapeutics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

8. Global Liposome Drug Delivery Market, By End User, 2019 - 2031, (USD Mn)

Overview
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
Hospitals
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Clinics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Research Laboratories
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)

9. Global Liposome Drug Delivery Market, By Region, 2019 - 2031, (USD Mn)

Introduction
- Market Share Analysis, By Region, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2031
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.S.
Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Mn)
GCC
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Technology, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Indication, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Mn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Mn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Company Profiles
Gilead Sciences, Inc. *
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Luye Pharma Group
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Ipsen Biopharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Pacira Pharmaceuticals, Inc.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Acuitas Therapeutics
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
LIPOSOMA B.V.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Takeda Pharmaceutical Company Limited
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Taiwan Liposome Company, Ltd.
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Endo International
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies
Jazz Pharmaceuticals plc
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Market Strategies

11. Analyst View

Wheel of Fortune
Analyst View
Coherent Opportunity Map

12. References and Research Methodology

References
Research Methodology
About us and Sales Contact